Teva's 1st-qtr sales down, mainly hit by Copaxone competition
Ajovy, Teva's migraine drug, recommended by UK's NICE.
Infographic: Navigating through the clinical trials of monoclonal antibodies targeting the CGRP pathway
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ANJL4AXVTBOMDKS2X4DIJZXZAY.jpg "Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters")
Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters
US FDA accepts Teva-MedinCell's NDA for drug to treat schizophrenia
Thomas Thoma | Clinical Trials Europe
Teva Pharmaceutical Industries Ltd. - We're proud to celebrate #InternationalWomensDay. Allow us to introduce Paula Turner, who leads Teva's clinical trial facility and who has dedicated her career to protecting patients. Discover
Teva Acquires Labrys Expands CNS Portfolio
Is Teva late reporting EU clinical trials?
California Judge Rules for Drugmakers in Opioid Trial. Teva Stock Is Surging. | Barron's
3rd Annual Clinical Trials Summit BARCELONA 2019 | GR BioResearch
Free Stock Alerts for Clinical Drug Trials Regeneron Pharmacueticals and Teva Pharmaceutical Report Positive Topline Phase 3 Clinical Trial Results of Fasinumab - Free Stock Alerts for Clinical Drug Trials
Teva Pharmaceuticals Near 20-Year Lows (NYSE:TEVA) | Seeking Alpha
Teva's Austedo fails in two paediatric Tourette's syndrome trials | Pharmafile
Work as Clinical Trials Subject Recruiter at Teva Pharmaceuticals | PharmaTutor
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan
New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel
New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Xconomy: 89Bio Joins NASH Chase with a Teva Drug and $60M in Funding
Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market - Clinical Trials Arena
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
